Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. - Wikidata - awgldk - TriplyDB

Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL.

Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL.

http://www.wikidata.org/entity/Q36471285

about

The cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis Mechanisms of HIV-associated lymphocyte apoptosis: 2010 Role of the Fas/FasL pathway in HIV or SIV disease Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS Microbial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus Disease.Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease.Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.Temporal association of large granular lymphocytosis, neutropenia, proviral load, and FasL mRNA in cats with acute feline immunodeficiency virus infection.

P2860

Q30406147-35FA6149-2943-4CE1-8775-6C605B0FFC8F Q34245386-EA6D46B1-B1A1-48C5-8633-28CEC78C8A10 Q34261832-78B41D95-7E60-4BC4-90A4-37CA4272384F Q34545417-61CFA9B8-7153-4DFF-B5C2-3CDB2361DAF2 Q34612821-CCD16E81-9913-4317-BEB4-4D1F383096AE Q35018048-CADC9615-B5D1-4F08-984A-32D71B067141 Q35585948-1FAB1539-3CB0-409C-B70F-AE6E9A55361C Q36803857-42051444-7DFE-47D0-ADAF-7473902B0826 Q37015889-5BA5C24B-B0F2-42FC-A7C5-2C712AF7CB62 Q37295142-B63530A5-A59D-4CD9-80B0-E63351038528 Q37734746-4F747EB7-4D20-416F-A78F-5BB09745CF07 Q37912497-861B64F2-E7CB-4143-A699-DD3E47FCDB3B Q39810780-8E8841E7-763C-409E-B5BD-81E65A9CDA38 Q41338220-0198405B-7C8A-4279-888E-ACB0C2A6B731 Q41810287-78FE9524-5167-47FE-B5E7-CF4A9470C5B5

P2860

Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL.

http://www.wikidata.org/entity/Q36471285

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@ast

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@en

type

label

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@ast

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@en

prefLabel

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@ast

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@en

P1433

Q36471285-F864A787-F929-42BA-A74F-52BD37E1BB63

P1476

Q36471285-D340500A-3C40-4145-8BF5-F5088E5130DD

P2093

Q36471285-29DD0C50-301C-4D1D-B7EA-B595F8766CDE

Q36471285-33A69AA2-BF64-4464-84A3-38CD449A230E

Q36471285-5E29EB33-6041-44A4-AFD2-F475193B901E

Q36471285-60C693CD-30D4-4D27-A64C-262C37C35F01

Q36471285-8371B443-EB1D-44F5-A065-0EBF59DD331F

Q36471285-D9C4A51F-B925-4D52-ABBF-F29C0A9A92C4

Q36471285-FD423D8C-0C6D-418F-8E06-917108257EB3

P2860

Q36471285-00ECBDA2-B1BB-467F-8460-646DC66B1FE4

Q36471285-094282B5-FF98-4E9D-A6AA-16CB7B0EC96D

Q36471285-0BD4284A-E12C-4CC9-B264-D83610931526

Q36471285-19FA71C5-D596-421F-8EFA-8DB0CC772B38

Q36471285-1BEFC084-B8C6-49B8-A871-F09E0886E2F6

Q36471285-3AF4C66D-5184-4509-AB4A-869413C2CE3F

Q36471285-3D9D75E4-D16E-4D61-8832-42A637C018AC

Q36471285-3DB521CD-D49B-46BD-9EAF-1C682F64AA4A

Q36471285-4621F8F6-9D5F-4C10-9CCE-A5C67C9D5D3A

Q36471285-48908299-CADC-420E-80F3-F45C506A197D

P304

Q36471285-3D082063-2FAD-4215-96F3-D6A975782E7A

P31

Q36471285-71B57BEB-51E6-45C8-8161-6F9811CF30F8

P356

Q36471285-814AA5D3-2F1D-4288-826D-A125DDF8DCB9

P478

Q36471285-EA9C7534-7895-4ED4-96F1-01091AD2A14C

P577

Q36471285-F2553BB0-84ED-4518-B9BA-32FDD1F40035

P5875

Q36471285-6D641CDE-431B-433D-8B92-E8307E95484D

P698

Q36471285-A7A43F71-A4E2-4EBC-A3CE-7033B479D78A

P932

Q36471285-5FEB114E-E8E7-4C22-97BB-09E8010911B1

P356

P1433

Clinical and Developmental Immunology

P1476

Attenuated disease in SIV-infe ...... oclonal antibody against FasL.

@en

P2093

C Cameron Yin

http://www.w3.org/2001/XMLSchema#string

C David Pauza

http://www.w3.org/2001/XMLSchema#string

Hideo Yagita

http://www.w3.org/2001/XMLSchema#string

Ilia Tikhonov

http://www.w3.org/2001/XMLSchema#string

Ko Okumura

http://www.w3.org/2001/XMLSchema#string

Maria S Salvato

http://www.w3.org/2001/XMLSchema#string

Toshihiro Maeda

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell

Viral immune evasion due to persistence of activated T cells without effector function

Limited durability of viral control following treated acute HIV infection

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.

Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment.

High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression

Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.

HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter.

P304

93462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2007/93462

http://www.w3.org/2001/XMLSchema#string

P478

2007

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5533781

http://www.w3.org/2001/XMLSchema#string

P698

18317535

http://www.w3.org/2001/XMLSchema#string

P932

2248700

http://www.w3.org/2001/XMLSchema#string